1,3,5,8-Tetrahydroxyxanthone regulates ANGPTL3–LPL pathway to lessen the ketosis in mice

Ketosis is a metabolic disorder closely associated with both lipid and carbohydrate metabolism. Recent studies show that angiopoietin-like protein 3 (ANGPTL3) contributes to the development of metabolic disorder. The objective of this study was to explore the inhibitory effect of 1,3,5,8-tetrahydroxyxanthone (Xan), a naturally occurring flavonoid compound, on ketosis and the mechanisms involved in this regulation. After 4 weeks, Xan (10 or 30 mg/kg, intragastrically) treatment decreased plasma total ketone bodies, malondialdehyde, 8-isoprostane, triglyceride, total cholesterol levels, and hepatic ANGPTL3 expression concomitantly with increased plasma glucose concentration and adipose lipoprotein lipase (LPL) expression in ketosis murine. The present results suggest that Xan regulates ANGPTL3–LPL pathway to lessen the ketosis in mice.

Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (44 K)Download as PowerPoint slide